Page 23 - Administration Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By City News Service Feb 27, 2021 LOS ANGELES (CNS) - Grade crossings at four streets along a Metrolink line in Palmdale and Lancaster will be enhanced for safety using up to $13.6 million in funds awarded to the rail system through the Federal Highway Administration Section 130 Program.   The safety improvements will take place at street crossings along its Antelope Valley Line, at avenues J and K in Lancaster, Avenue P in Palmdale and Avenue M, which encompasses both cities, Metrolink said.   Enhancements include automatic pedestrian gates with emergency exit swing gates, changes to th...

Philippine Health Insurance Corporation (PhilHealth) (MANILA BULLETIN) The filing of charges stemmed from the findings of the National Bureau of Investigation-Central Visayas regarding the case of a 41-year-old male patient who was admitted at Chong Hua Hospital (CHH) last March 30, 2020 after experiencing difficulty in breathing.   The patient, who was said to be jobless the last 10 years, was later transferred to the Vicente Sotto Memorial Medical Center (VSMCC) where he eventually died due to Hepatic Encephalopathy or Acute Decomponsated Liver Cirrhosis as secondary cause.   However, The...

02/08/21 National Workers Compensation Defense Network (NWCDN) Industrial Commission Policy Update on In-Person Hearings, Mediations, and Other Procedural Directives.The North Carolina Industrial Commission has adopted an Emergency Rule that in turn allows the Industrial Commission to implement Emergency Orders and Directives of the Chief Justice of the North Carolina Supreme Court. In short, the Industrial Commission wants its operating structure to be in sync with, and operate consistently with, the civil system when it comes to holding hearings, mediations and other procedural directives...

Share this article Share this article TITUSVILLE, N.J., Jan. 21, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen's rilpivirine and ViiV Healthcare's cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's 25-year commitment to make HIV history. In the U.S., ...